Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Contraception
- Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV.Contraception. 2007; 75: 407-419
Gallo MF, Steiner MJ, Hobbs MM, Warner L, Jamieson DJ, Macaluso M. Biological markers of semen exposure: tools for improving the assessment of sexual behavior in HIV/STI prevention research. [submitted to AIDS & Behav] 2012.
- Postcoital detection of a male-specific semen protein. Application to the investigation of rape..N Engl J Med. 1985; 312: 338-343
- Critical next steps for female condom research–report from a workshop.Contraception. 2009; 79: 339-344
- SILCS diaphragm: postcoital testing of a new single-size contraceptive device.Contraception. 2008; 78: 237-244
- Evaluation of semen detection in vaginal secretions: comparison of four methods.Am J Reprod Immunol. 2008; 60: 274-281
- Abacus Diagnostics, West Hills, CA. ABAcard [cited 2012 April 27].(Available from)
- Evaluation of prostate-specific antigen (PSA) membrane test assays for the forensic identification of seminal fluid.J Forensic Sci. 1999; 44: 1057-1060
- Good performance of rapid prostate-specific antigen test for detection of semen exposure in women: implications for qualitative research.Sex Transm Dis. 2009; 36: 501-506
- Abbott Diagnostics, Abbott Park, IL. ARCHITECT i2000SR [cited 2012 April 27].(Available from)http://www.abbottdiagnostics.com/Products/Instruments_by_Platform/default.cfm?system=ARCHITECT&suffix=i2000sr®=us
- Effectiveness of female and male condoms in preventing exposure to semen during vaginal intercourse: a randomized trial.Contraception. 2005; 71: 130-136
- Efficacy of the female condom as a barrier to semen during intercourse.Am J Epidemiol. 2003; 157: 289-297
- Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure.Contraception. 1999; 59: 195-201
- WHO Clinical management of rape survivors: developing protocols for use with refugees and internally displaced persons -- Revised ed. Annex 7 Forensic Examination Page 52; [cited 2012 April 27].(Available from)
- Evaluation of the BioSign PSA membrane test for the identification of semen stains in forensic casework.N Z Med J. 2002; 115: 48-49
- The detection by Enzyme Linked Immunosorbent Assay of P30 and 19-OH Prostaglandin F1/F2, in the presence of a range of possible contaminants.Sci Justice. 1998; 38: 157-164
- Detection of prostate specific antigen by ELISA.J Forensic Sci. 1993; 38: 250-258
- An enzyme-linked immunosorbent assay (ELISA) for prostate-specific antigen.Forensic Sci Int. 1991; 50: 125-138
- Inhibitory effect of lubricants and a vaginal contraceptive gel on detection of biomarkers of semen exposure. [abstract]. International Society for STD Research, London2009
- Validation of the One Step ABAcard TM PSA test for the rapid forensic identification of semen. Report from Miami Dade Police Department, 1998
- Identification of human semenogelin in membrane strip test as an alternative method for the detection of semen.Forensic Sci Int. 2007; 169: 27-31
- False positives observed on the Seratec(®) PSA semiquant cassette test with condom lubricants.J Forensic Sci. 2012; ([Epub ahead of print])
- Evaluation of semen presumptive tests for use at crime scenes.Med Sci Law. 2011; 51: 11-17
- Vaginal swab specimen processing methods influence performance of rapid semen detection tests: a cautionary tale.Contraception. 2010; 82 ([Epub 2010 Apr 13]): 291-295
- Predictors of unprotected sex among female sex workers in Madagascar: comparing semen biomarkers and self-reported data.AIDS Behav. 2010; 14: 1279-1286
- Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe.Am J Epidemiol. 2009; 170: 918-924
☆The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
☆☆Use of trade names is for identification only and does not imply endorsement by the US Department of Health and Human Services.